全部照片(1)
About This Item
經驗公式（希爾表示法）:
C4H12Cl2O2PtS2
CAS號碼:
分子量：:
422.25
MDL號碼:
分類程式碼代碼:
12161600
PubChem物質ID:
NACRES:
NA.22
推薦產品
品質等級
化驗
97%
形狀
solid
反應適用性
core: platinum
reagent type: catalyst
mp
218-224 °C
SMILES 字串
Cl[Pt]Cl.CS(C)=O.CS(C)=O
InChI
1S/2C2H6OS.2ClH.Pt/c2*1-4(2)3;;;/h2*1-2H3;2*1H;/q;;;;+2/p-2
InChI 密鑰
KDADQDWVKZJTDQ-UHFFFAOYSA-L
一般說明
顺式二氯双(二甲基硫亚砜)合铂（II）是一种钯复合物，可用作多种化学反应的催化剂，包括多氟芳基亚胺的甲基化和甲烷氧化。它是一种有效的C-F 活化预催化剂（precatalyst）。
應用
顺式二氯双(二甲基硫亚砜)合铂（II）可用作：
- 发烟硫酸介导的（SO3-H2SO4）甲烷氧化形成硫酸甲酯（MBS）的催化剂。
- 环金属复合物合成的前体。
訊號詞
Warning
危險聲明
危險分類
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
客戶也查看了
R S Dewoskin et al.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 9(4), 529-537 (1993-07-01)
The effects of hyperthermia (HY) on cisplatin (CDDP) nephrotoxicity and kidney metal concentrations were evaluated in female F344 rats. Rats were anaesthetized with a xylazine/ketamine mixture, heated on a water-bed for 1 h to an intraperitoneal temperature of 41.1 +/-
L Türkeri et al.
International urology and nephrology, 25(3), 259-263 (1993-01-01)
Traditional approaches for the treatment of locally advanced bladder tumours may not be sufficient enough. Neoadjuvant chemotherapy, a new modality, may be beneficial by enhancing the local and systemic control of the disease. The background of this new modality and
Osteosarcoma in adolescents and young adults: new developments and controversies. Thermal chemosensitization of cDDP-resistant cells.
A W Konings et al.
Cancer treatment and research, 62, 93-100 (1993-01-01)
H Nakagawa et al.
Journal of neuro-oncology, 16(1), 61-67 (1993-04-01)
The distribution of cis-diamminedichloroplatinum (CDDP) was studied in 23 patients undergoing surgical resection of brain tumors metastatic from lung cancer. CDDP (100 mg/m2) was administered intravenously (i.v.) or intra-arterially (IA) at the time of surgery, and various fluids and tissues
J M Bachaud et al.
Bulletin du cancer, 81(3), 212-218 (1994-03-01)
In order to enhance radiation effects in the treatment of unresectable Head and Neck squamous cell carcinoma, we initiated a phase I-II study in February 1991 with concomitant radiation and cisplatin in the treatment of resectable Head and Neck squamous
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務